Jean Van Rampelbergh is an experienced professional in the field of clinical development and regulatory affairs. Currently serving as the Chief Clinical Development Officer at Imcyse SA, Jean plays a crucial role in advancing clinical programs for auto-immune diseases. With a background in Biomedical Sciences and extensive experience in various roles at companies like Novellas Healthcare and sanofi-aventis, Jean has a proven track record in the healthcare sector.
December, 2021 - present
January, 2020
March, 2016
Executive Vice President, Chief Clinical Development Officer at Ionis Pharmaceuticals
Chief Clinical Development Officer at HMNC Brain Health
Chief Clinical Development Officer at Stealth BioTherapeutics
Chief Clinical Development Officer at GTBiopharma
EVP & Chief Clinical Development Officer at Inhibrx